Jonathan Graham Selected Research

Jonathan Graham Research Topics

2	Herpes Zoster 03/2022 - 07/2016
2	Disease Progression 01/2009 - 04/2007
2	Relapsing-Remitting Multiple Sclerosis 01/2009 - 04/2007
1	Cytomegalovirus Infections (Inclusion Disease) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020
1	Chickenpox 01/2020
1	Human Influenza (Influenza) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2018
1	Neoplasms (Cancer) 06/2018
1	Postherpetic Neuralgia 07/2016
1	Anaphylaxis (Anaphylactic Shock) 07/2016
1	Chronic Urticaria 01/2016
1	Diphtheria 01/2015
1	Whooping Cough (Pertussis) 01/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Tetanus 01/2015
1	Multiple Sclerosis 04/2007

4	VaccinesIBA 03/2022 - 01/2015
2	Glatiramer Acetate (Copaxone)FDA Link 01/2009 - 04/2007
1	letermovirIBA 01/2021
1	Particulate MatterIBA 01/2020
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2020
1	SmokeIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 06/2018
1	AfatinibIBA 06/2018
1	Tyrosine Kinase InhibitorsIBA 06/2018
1	Herpes Zoster VaccineIBA 07/2016
1	GelatinIBA 07/2016
1	Neomycin FDA LinkGeneric 07/2016
1	Omalizumab (Xolair)FDA Link 01/2016
1	A-factor (Streptomyces)IBA 01/2015
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2015
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 01/2015
1	Natalizumab (Tysabri)FDA Link 01/2009
1	InterferonsIBA 04/2007
1	Interferon beta-1a FDA Link 04/2007

1	Cell Transplantation 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 04/2007
1	Immunomodulation 04/2007